Eric L. Ross, MD

Department of Psychiatry, Larner College of Medicine, University of Vermont, Burlington, Vermont

  • 2Articles
  • 8.2KReads
  • 2020–2025Active
  • 9Collaborators
  • 15Citations

About

Eric L. Ross, MD is affiliated with Department of Psychiatry, Larner College of Medicine, University of Vermont, Burlington, Vermont. Eric L. Ross has authored or co-authored 2 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2020 and 2025. Their work focuses on Depression (MDD), Encephalitis, and Rare Diseases.

Publications

JCP
Aripiprazole or Bupropion Augmentation vs Switching to Bupropion in Treatment Resistant Depression
Original Research

Aripiprazole or Bupropion Augmentation vs Switching to Bupropion in Treatment Resistant Depression

September 22, 2025

In this model, augmentation with bupropion better balanced efficacy and tolerability in TRD in adults under 85 than did switching to bupropion or augmentation with aripiprazole. Augmentation with aripiprazole...
, , , et al
JCP
Original Research

Routine Screening for Autoimmune Encephalitis

November 17, 2020

Autoimmune encephalitis (AE) is a highly treatable neurologic condition that can cause psychosis. This study estimated the cost-effectiveness of routine screening for AE compared with clinically targeted screening in...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe